PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Epigenomic Medicine, Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC, 3004, Australia; School of Science, College of Science, Engineering & Health, RMIT University, VIC, 3001, Australia.\', \'Epigenomic Medicine, Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC, 3004, Australia.\', \'School of Science, College of Science, Engineering & Health, RMIT University, VIC, 3001, Australia.\', \'Epigenomic Medicine, Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC, 3004, Australia; Department of Clinical Pathology, The University of Melbourne, Parkville, VIC, 3052, Australia. Electronic address: tom.karagiannis@monash.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1093-3263(21)00020-610.1016/j.jmgm.2021.107851
?:doi
?:hasPublicationType
?:journal
  • Journal of molecular graphics & modelling
is ?:pmid of
?:pmid
?:pmid
  • 33556646
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Interaction of small molecules with the SARS-CoV-2 papain-like protease: In silico studies and in vitro validation of protease activity inhibition using an enzymatic inhibition assay.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all